155 related articles for article (PubMed ID: 25518509)
1. [A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease].
Galeeva ZM; Galiavich AS
Ter Arkh; 2014; 86(9):71-6. PubMed ID: 25518509
[TBL] [Abstract][Full Text] [Related]
2. [Effect of combination antihypertensive therapy on circadian blood pressure and metabolic parameters in patients with type 2 diabetes mellitus].
Statsenko ME; Derevianchenko MV; Pastukhova OR
Kardiologiia; 2014; 54(11):20-4. PubMed ID: 25902654
[TBL] [Abstract][Full Text] [Related]
3. [Results of the Russian EKSPERT program: post-marketing supervision over efficacy and influence of the preparation Ekvator on quality of life at out-patients with arterial hypertension].
Glezer MG; Vygodin VA; Avakian AA; Prokof'eva EB
Kardiologiia; 2014; 54(3):15-22. PubMed ID: 25102744
[TBL] [Abstract][Full Text] [Related]
4. [A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia].
Podzolkov VI; Bragina AE; Osadchiy KK
Ter Arkh; 2017; 89(12):133-140. PubMed ID: 29411773
[TBL] [Abstract][Full Text] [Related]
5. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
Hong SJ; Jeong HS; Cho JM; Chang K; Pyun WB; Ahn Y; Hyon MS; Kang WC; Lee JH; Kim HS
Clin Ther; 2019 Feb; 41(2):233-248.e9. PubMed ID: 30665829
[TBL] [Abstract][Full Text] [Related]
7. Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Muntner P; Levitan EB; Lynch AI; Simpson LM; Whittle J; Davis BR; Kostis JB; Whelton PK; Oparil S
J Clin Hypertens (Greenwich); 2014 May; 16(5):323-30. PubMed ID: 24739073
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia.
Jin X; Kim MH; Han KH; Hong SJ; Ahn JC; Sung JH; Cho JM; Lee HC; Choi SY; Lee K; Kim WS; Rhee MY; Kim JH; Hong SP; Yoo BS; Cho EJ; Lee JH; Kim PJ; Park CG; Hyon MS; Shin JH; Lee SH; Sung KC; Hwang J; Kwon K; Chae IH; Seo JS; Kim H; Lee H; Cho Y; Kim HS
J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1835-1845. PubMed ID: 32937023
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).
Motozato K; Miura S; Shiga Y; Kusumoto T; Adachi S; Inoue T; Fujisawa K; Saku K
Clin Exp Hypertens; 2016; 38(1):45-50. PubMed ID: 26268636
[TBL] [Abstract][Full Text] [Related]
10. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
Simonyi G; Ferenci T
Orv Hetil; 2016 Jan; 157(1):30-4. PubMed ID: 26708684
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Fimasartan and Rosuvastatin Combination Treatment in Hypertensive Patients With Dyslipidemia.
Lee SJ; Oh J; Hong SJ; Cho IJ; Kim SR; Uhm JS; Shim CY; Chang HJ; Ahn CM; Kim JS; Kim BK; Park S; Lee SH; Hong GR; Ko YG; Choi D
Clin Ther; 2020 Jun; 42(6):1058-1066.e3. PubMed ID: 32376036
[TBL] [Abstract][Full Text] [Related]
12. [Modern Fixed Combinations in the Correction of Arterial Hypertension and Dyslipidemia].
Galeeva ZM; Galyavich AS; Baleeva LV; Sabirzyanova AA; Kuznetsov MV
Kardiologiia; 2024 May; 64(5):26-32. PubMed ID: 38841786
[TBL] [Abstract][Full Text] [Related]
13. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
Statsenko ME; Derevianchenko MV
Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
[TBL] [Abstract][Full Text] [Related]
14. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
Ferdinand KC; Davidson MH; Kelly MT; Setze CM
Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674
[TBL] [Abstract][Full Text] [Related]
15. [Treatment for dyslipidemias in patients with arterial hypertension].
Chazova IE; Kukharchuk VV; Ratova LG; Kaminnaia VI
Ter Arkh; 2007; 79(4):53-7. PubMed ID: 17564020
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
[TBL] [Abstract][Full Text] [Related]
17. Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
Roth EM; Rosenson RS; Jones PH; Davidson MH; Kelly MT; Setze CM; Lele A; Thakker K
J Clin Lipidol; 2012; 6(6):534-44. PubMed ID: 23312049
[TBL] [Abstract][Full Text] [Related]
18. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
Bobrie G;
Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
Kim TS; Rha SW; Kim SY; Park DG; Sung KC; Yoon MH; Kim KH; Lee HC; Kim WS; Kim YJ; Ahn JC; Rhee MY; Cha DH; Yoo BS; Park SH; Yoo KD; Jeon DW; Yoon YW; Cho SK; Oh YS
Clin Ther; 2019 Apr; 41(4):728-741. PubMed ID: 30904178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
